全文获取类型
收费全文 | 2008篇 |
免费 | 138篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 68篇 |
妇产科学 | 28篇 |
基础医学 | 427篇 |
口腔科学 | 19篇 |
临床医学 | 267篇 |
内科学 | 336篇 |
皮肤病学 | 31篇 |
神经病学 | 268篇 |
特种医学 | 32篇 |
外科学 | 247篇 |
综合类 | 9篇 |
预防医学 | 116篇 |
眼科学 | 14篇 |
药学 | 133篇 |
肿瘤学 | 164篇 |
出版年
2024年 | 2篇 |
2023年 | 20篇 |
2022年 | 21篇 |
2021年 | 53篇 |
2020年 | 35篇 |
2019年 | 65篇 |
2018年 | 72篇 |
2017年 | 43篇 |
2016年 | 58篇 |
2015年 | 64篇 |
2014年 | 78篇 |
2013年 | 95篇 |
2012年 | 161篇 |
2011年 | 173篇 |
2010年 | 85篇 |
2009年 | 112篇 |
2008年 | 135篇 |
2007年 | 145篇 |
2006年 | 142篇 |
2005年 | 154篇 |
2004年 | 117篇 |
2003年 | 104篇 |
2002年 | 106篇 |
2001年 | 13篇 |
2000年 | 3篇 |
1999年 | 10篇 |
1998年 | 23篇 |
1997年 | 13篇 |
1996年 | 10篇 |
1995年 | 12篇 |
1994年 | 9篇 |
1993年 | 8篇 |
1992年 | 2篇 |
1991年 | 2篇 |
1990年 | 5篇 |
1989年 | 2篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1982年 | 1篇 |
1978年 | 1篇 |
排序方式: 共有2160条查询结果,搜索用时 15 毫秒
31.
Arnaud Jabouille Maylis Delugin Rapha?l Pineau Alexandre Dubrac Fabienne Soulet Stéphanie Lhomond Nestor Pallares-Lupon Hervé Prats Andreas Bikfalvi Eric Chevet Christian Touriol Michel Moenner 《Oncotarget》2015,6(28):24922-24934
IRE1α is an endoplasmic reticulum (ER)-resident transmembrane signaling protein and a cellular stress sensor. The protein harbors a cytosolic dual kinase/endoribonuclease activity required for adaptive responses to micro-environmental changes. In an orthotopic xenograft model of human glioma, invalidation of IRE1α RNase or/and kinase activities generated tumors with remarkably distinct phenotypes. Contrasting with the extensive angiogenesis observed in tumors derived from control cells, the double kinase/RNase invalidation reprogrammed mesenchymal differentiation of cancer cells and produced avascular and infiltrative glioblastomas with blood vessel co-option. In comparison, selective invalidation of IRE1α RNase did not compromise tumor angiogenesis but still elicited invasive features and vessel co-option. In vitro, IRE1α RNase deficient cells were also endowed with a higher ability to migrate. Constitutive activation of both enzymes led to wild-type-like lesions. The presence of IRE1α, but not its RNase activity, is therefore required for glioblastoma neovascularization, whereas invasion results only from RNase inhibition. In this model, two key mechanisms of tumor progression and cancer cell survival are functionally linked to IRE1α. 相似文献
32.
33.
Risk behaviors are well known to be higher in adolescents and emerging adults. Drug use and delinquency present several common predictive factors. The aim of the present study was to assess the contribution of individual factors (aggression, impulsivity, empathy, and cognitive distortions) to delinquent behaviors, alcohol use and cannabis consumption among adolescents and emerging adults. Participants were between 15 and 25 years of age (M = 18.64 years, SD = 2.61); 325 were adolescents (15–18 years of age, M = 16.56, SD = 1.11, 56.31% of women) and 283 were emerging adults (19–25 years, M = 21.03, SD = 1.62, 50.88% of women). They completed self-report validated questionnaires. Multiple regression analyses showed that all individual factors significantly predicted delinquency. Impulsivity and empathy significantly predicted alcohol use. Concerning cannabis use, impulsivity is the only significantly associated predictor. Moderation analysis showed that specific associations were stronger in adolescents, whereas others were stronger in emerging adults. All these variables explained 69% of the variance of delinquency, 31% of the variance of alcohol use, and 18% of the variance of cannabis use. This model demonstrated acceptable goodness-of-fit criteria. These results may have implications for prevention and intervention. 相似文献
34.
Lydie Canier Nimol Khim Saorin Kim Rotha Eam Chanra Khean Kaknika Loch Malen Ken Pieter Pannus Philippe Bosman Jorgen Stassijns Fabienne Nackers SweetC Alipon Meng Chuor Char Nguon Chea William Etienne Martin De Smet Jean-Marie Kindermans Didier Ménard 《The American journal of tropical medicine and hygiene》2015,92(3):573-577
In the context of malaria elimination, novel strategies for detecting very low malaria parasite densities in asymptomatic individuals are needed. One of the major limitations of the malaria parasite detection methods is the volume of blood samples being analyzed. The objective of the study was to compare the diagnostic accuracy of a malaria polymerase chain reaction assay, from dried blood spots (DBS, 5 μL) and different volumes of venous blood (50 μL, 200 μL, and 1 mL). The limit of detection of the polymerase chain reaction assay, using calibrated Plasmodium falciparum blood dilutions, showed that venous blood samples (50 μL, 200 μL, 1 mL) combined with Qiagen extraction methods gave a similar threshold of 100 parasites/mL, ∼100-fold lower than 5 μL DBS/Instagene method. On a set of 521 field samples, collected in two different transmission areas in northern Cambodia, no significant difference in the proportion of parasite carriers, regardless of the methods used was found. The 5 μL DBS method missed 27% of the samples detected by the 1 mL venous blood method, but most of the missed parasites carriers were infected by Plasmodium vivax (84%). The remaining missed P. falciparum parasite carriers (N = 3) were only detected in high-transmission areas. 相似文献
35.
36.
Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5‐Azacytidine
Kamel Laribi Nathalie Denizon Habib Ghnaya Mustapha Atlassi Anne Besançon Fabienne Pineau‐Vincent Philippe Gaulard Tony Petrella 《European journal of haematology》2014,93(1):81-85
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy which was first included as an independent cutaneous lymphoma in the 2008 World Health Organisation (WHO) classification (1). BPDCN usually has an extremely poor prognosis, with quick relapses after chemotherapy (2; 3). Here, we report two cases of patients diagnosed in 2011 with BPDCN and myelodysplasia, and who were treated for the first time with 5‐azacytidine (5‐Aza); a drug approved by the Food and Drug Administration (FDA) and mainly used in the treatment of myelodysplastic syndrome (Kaminskas E, et al. 2005 Clin Cancer Res, 11, 3604–8). The first case was an 81‐year‐old man who presented with unusual CD10+, CD56‐ immunohistochemistry and 45X, ‐Y abnormality using fluorescent in situ hybridization (FISH) analysis. The second case was a 78‐year‐old woman who manifested monosomy 13 and chromosome instability due to D13S319 locus deletion in 13q14 as determined by FISH. Both patients showed excellent responses of their skin lesions after one cycle of chemotherapy, and their hematological disease was stabilized; however, pulmonary sepsis set in, followed by neutropenia after the fourth and the fifth cycle of treatment, that is, eight and 9 months postdiagnosis, respectively, leading to patient death. 相似文献
37.
38.
An-Sofie Schoonjans Fabienne Marchau Bernard P. Paelinck Lieven Lagae Arnold Gammaitoni Milka Pringsheim 《Current medical research and opinion》2017,33(10):1773-1781
Objective: Dravet syndrome (DS) is a rare, treatment-resistant epilepsy syndrome for which current treatment regimens are often ineffective. Fenfluramine is currently in development for treatment of DS, based on reports in the 1980s and 1990s of its anti-epileptic activity in pediatric patients with intractable epilepsy. However, fenfluramine was withdrawn from global markets in 1997 following reports of its association with pulmonary hypertension and heart valve disease in adult patients treated for obesity. This review was conducted to assess cardiac safety of fenfluramine when used at lower doses for treatment of DS.Methods: Pubmed was searched for clinical studies of fenfluramine in obese adults who reported incidence of heart valve disease. These data were reviewed against published results from Belgian patients with DS who have been treated with low-dose fenfluramine for up to 28 years.Results: Nine controlled studies of fenfluramine and related compounds (dexfenfluramine and/or phentermine) which assessed incidence and severity of cardiac valve disease in 3,268 treated patients and 2,017 control subjects have been reported. Mild or greater aortic valve regurgitation was found in 9.6% of treated patients compared with 3.9% of control subjects, and moderate or greater mitral valve regurgitation was found in 3.1% of treated patients and 2.5% of control subjects. Nineteen DS patients have been treated for up to 28 years with 10–20?mg/day fenfluramine, with no clinical signs or symptoms of cardiac valve disease or pulmonary hypertension. Slight and clinically unimportant changes in valve structure have been seen on echocardiography in five patients at some time during the observation period.Conclusions: A different benefit-risk relationship appears to be emerging when fenfluramine is used at low doses for extended periods in young patients with DS. Continued cardiac assessments during ongoing Phase 3 clinical trials will provide additional safety information for this potential new and effective treatment. 相似文献
39.
Fabienne?Langlois Randall?Woltjer Justin?S.?Cetas Maria?FleseriuEmail authorView authors OrcID profile 《Pituitary》2018,21(2):194-202
Silent growth hormone adenomas (SGHA) are a rare entity of non-functioning pituitary neuroendocrine tumors. Diagnosis is invariably made post-operatively of a tumor immunopositive for GH (and Pit-1 in selected cases) but without clinical acromegaly. Mainly young females are affected, and tumors are often uncovered by investigation for headaches or oligoamenorrhea. Integration of clinical, pathological and biochemical data is required for proper diagnosis. Beside normal IGF-1 levels, a third of SGHAs displays elevated GH levels and some will eventually progress to acromegaly. Almost two-thirds will be mixed GH-prolactin tumors and sparsely-granulated monohormonal GH tumors seems the more aggressive subtype. Recurrence and need for radiation is higher than other non-functioning tumors so close follow-up is warranted. 相似文献
40.
Structural and Functional Impact of Parkinson Disease‐Associated Mutations in the E3 Ubiquitin Ligase Parkin 下载免费PDF全文
Fabienne C. Fiesel Thomas R. Caulfield Elisabeth L. Moussaud‐Lamodière Kotaro Ogaki Daniel F.A.R. Dourado Samuel C. Flores Owen A. Ross Wolfdieter Springer 《Human mutation》2015,36(8):774-786
Mutations in the PARKIN/PARK2 gene that result in loss‐of‐function of the encoded, neuroprotective E3 ubiquitin ligase Parkin cause recessive, familial early‐onset Parkinson disease. As an increasing number of rare Parkin sequence variants with unclear pathogenicity are identified, structure–function analyses will be critical to determine their disease relevance. Depending on the specific amino acids affected, several distinct pathomechanisms can result in loss of Parkin function. These include disruption of overall Parkin folding, decreased solubility, and protein aggregation. However pathogenic effects can also result from misregulation of Parkin autoinhibition and of its enzymatic functions. In addition, interference of binding to coenzymes, substrates, and adaptor proteins can affect its catalytic activity too. Herein, we have performed a comprehensive structural and functional analysis of 21 PARK2 missense mutations distributed across the individual protein domains. Using this combined approach, we were able to pinpoint some of the pathogenic mechanisms of individual sequence variants. Similar analyses will be critical in gaining a complete understanding of the complex regulations and enzymatic functions of Parkin. These studies will not only highlight the important residues, but will also help to develop novel therapeutics aimed at activating and preserving an active, neuroprotective form of Parkin. 相似文献